than other countries like China, Spain and Italy seems to be because obesity is much more common here, Spring said. The higher rate of severe cases of COVID-19 among young adults in the U.S. The direction we’ve gone in with Opt-IN is to meet people where they are, and these days – especially during the COVID-19 pandemic – that means in their homes. “All these traditional treatments have not been scalable because they’re not accessible,” said Spring, who also is the chief of behavioral medicine in the department of preventive medicine at Feinberg. She cited reasons such as users having a hard time getting to the in-person meetings because of childcare or transportation challenges.
to try to make the DPP treatment more accessible and affordable, like offering it in YMCAs, uptake has been minimal. Spring said while there has been a lot of effort made in the U.S. Opt-IN is fully remote and costs participants between $324 and $427, depending on their package. “What’s novel is how participants get there."Ĭompared to the DPP treatment – a year-long program costing around $1,500 that requires weekly 90-minute in-person meetings with highly trained and paid medical professionals – the Opt-IN program is cheaper and much less burdensome, Spring said. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine. “This matches the gold standard, so it’s as good as it gets,” said senior study author Bonnie Spring, director of the Institute for Public Health and Medicine’s Center for Behavior and Health and co-leader of the Cancer Prevention Program at the Robert H. We want to meet people where they are, and these days – especially during the COVID-19 pandemic – that means in their homes.” Bonnie Springĭirector of the Institute for Public Health and Medicine’s Center for Behavior and Health at Northwestern University Feinberg School of Medicine The study findings will be published July 14 in the journal Obesity, the primary obesity publication.
Weight loss program trial#
According to a new study, the Opt-IN program helped participants in a clinical trial lose 11 to 13 pounds, which is equivalent to the DPP’s success rate. adults are overweight or obese, according to the Centers for Disease Control and Prevention.Ī new Northwestern Medicine remote weight-loss program, called Opt-IN, provides maximum weight loss for the lowest cost and with much less hassle than the gold-standard National Diabetes Prevention Program (DPP), the most successful behavioral non-drug treatment currently available. Losing weight during the COVID-19 pandemic has increasing urgency because obesity increases the risk of severe disease and death.
0 kommentar(er)
